Schumer blocks drug pricing measure during Senate fight, seeking larger action

Schumer blocks drug pricing measure during Senate fight, seeking larger action
© Greg Nash

Senate Minority Leader Charles SchumerCharles (Chuck) Ellis SchumerTurf war derails bipartisan push on surprise medical bills Senate confirms Trump's nominee to lead FDA CEO group pushes Trump, Congress on paid family, medical leave MORE (D-N.Y.) on Wednesday objected to a bipartisan bill to lower prescription drug prices that a top Republican was seeking to pass unanimously, arguing that larger action is needed instead of a piecemeal approach. 

The move came amid a tense back-and-forth on the floor among multiple senators from both parties over lowering the cost of drugs, an intensely debated issue that is a rare area of possible bipartisan action this year. 

Sen. John CornynJohn CornynTrump scramble to rack up accomplishments gives conservatives heartburn On The Money: Trump, China announce 'Phase One' trade deal | Supreme Court takes up fight over Trump financial records | House panel schedules hearing, vote on new NAFTA deal On The Money: Lawmakers strike spending deal | US, China reach limited trade deal ahead of tariff deadline | Lighthizer fails to quell GOP angst over new NAFTA MORE (R-Texas) was seeking to pass by unanimous consent a bill he is co-sponsoring with Sen. Richard Blumenthal (D-Conn.), which would crack down on drug companies gaming the patent system to delay competition from makers of cheaper generic drugs. 

But Schumer objected to the request, blocking the move. The New York Democrat said that while he did not oppose the bill on substantive grounds, he opposed Cornyn playing a “little game” to try to move only his bill forward without larger action to lower drug prices, which he said Republicans are blocking. 

“We have a whole lot of legislative ideas, not just his,” Schumer said on the floor. 

“His party blocks everything that would have far larger consequence,” Schumer added, speaking of Cornyn, who is up for reelection next year.

Schumer pointed to measures to allow Medicare to negotiate drug prices, as well as a bipartisan measure from Sens. Chuck GrassleyCharles (Chuck) Ernest GrassleyThe Hill's Morning Report — Sponsored by AdvaMed — House panel delays impeachment vote until Friday The Hill's Morning Report - Sponsored by AdvaMed - House panel expected to approve impeachment articles Thursday Horowitz did not find evidence Obama asked for probe of Trump MORE (R-Iowa) and Ron WydenRonald (Ron) Lee WydenThe Hill's Morning Report — Sponsored by AdvaMed — House panel delays impeachment vote until Friday Senators zero in on shadowy court at center of IG report Trump administration approves Medicaid work requirements in South Carolina MORE (D-Ore.) as better options to lower drug prices. 

Cornyn responded that Schumer’s move was “what people hate about Washington, D.C.” 

“My bill is not going to sink the prospects of that larger package of legislation,” Cornyn said, noting that his bill could pass on Wednesday.  

Cornyn also said any legislation must be bipartisan, noting that a proposal for Medicare to negotiate drug prices is not. 

"I'm not going to agree to price-fixing by the U.S. government," Cornyn said.  

Schumer also asked why Senate Majority Leader Mitch McConnellAddison (Mitch) Mitchell McConnellSherrod Brown backs new North American trade deal: 'This will be the first trade agreement I've ever voted for' McConnell: Bevin pardons 'completely inappropriate' House panel to hold hearing, vote on Trump's new NAFTA proposal MORE (R-Ky.), who controls the floor, had not scheduled any drug-pricing votes on Cornyn’s bill or others. Schumer told Cornyn to “go to the majority leader, who has prevented any debate on anything on drugs.”  

Schumer is also pushing for a vote on a House-passed bill aimed at protecting people with preexisting conditions as a prerequisite for opening up a drug-pricing debate on the Senate floor, seeking to highlight an issue that Democrats have effectively leveraged for political advantage to attack Republicans. 

Complicating matters for Schumer, a member of his caucus, Blumenthal, joined Cornyn on the floor to push for passage of the bill. 

“Sen. Blumenthal remains hopeful that this bill will pass as soon as possible,” a Blumenthal spokeswoman said after the moves on Wednesday. 

Sen. Dick DurbinRichard (Dick) Joseph DurbinLawmakers introduce bill taxing e-cigarettes to pay for anti-vaping campaigns Senators zero in on shadowy court at center of IG report Senate gears up for battle over witnesses in impeachment trial MORE (D-Ill.) also pushed on Wednesday to win unanimous consent for another drug-pricing bill, one he has sponsored with Grassley to require prices to be listed in TV advertisements for drugs. 

Sen. Pat ToomeyPatrick (Pat) Joseph ToomeyNSA improperly collected US phone records in October, new documents show Overnight Defense: Pick for South Korean envoy splits with Trump on nuclear threat | McCain blasts move to suspend Korean military exercises | White House defends Trump salute of North Korean general WH backpedals on Trump's 'due process' remark on guns MORE (R-Pa.) objected to that measure, saying that the legislation would provide seniors with misleading information because the list price of a drug is not usually the share that a senior actually pays, given insurance complications. Toomey also said the bill would “vilify” the pharmaceutical industry. 

“Let’s not stand in defense of pharmaceutical companies,” Durbin shot back to Toomey. “They’ve got plenty of people to defend them.”